Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms [177Lu]Lu DOTA-ABM-5G. |
Target- |
Action enhancers |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasm Metastasis | Phase 1 | United States | 01 Apr 2024 | |
metastatic non-small cell lung cancer | Phase 1 | United States | 22 Jan 2024 | |
Locally Advanced Pancreatic Adenocarcinoma | Phase 1 | United States | 18 Dec 2020 | |
Metastatic Pancreatic Cancer | Phase 1 | United States | 18 Dec 2020 |